ClinicalTrials.Veeva

Menu
S

Summit Clinical Research | Athens, GA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

APT-1011
Obeticholic Acid
TVB-2640
Cenicriviroc
Deudomperidone
TAK-906
Resmetirom
CIN-102
Elafibranor
CVC

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 15 total trials

A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES)

This study will determine the effect of oral 80 mg resmetirom administered once daily on participants with well-compensated non-alcoholic steatohepat...

Enrolling
NASH
Cirrhosis, Liver
Drug: Resmetirom
Drug: Placebo
Locations recently updated

The goal of this clinical trial is to evaluate if the study drug CIN-102 (deudomperidone) can help reduce the symptoms associated with diabetic gastr...

Enrolling
Diabetic Gastroparesis
Drug: Placebo
Drug: CIN-102 Dose 2

The overall objective of the RESTORATiVE303 study is to evaluate the safety and the Clostridioides difficile infection (CDI) recurrence rate at Week...

Enrolling
CDI
C.Difficile Diarrhea
Biological: Placebo
Biological: VE303

Trial sponsors

E
Exact Sciences Corporation logo
I
C
Genfit logo
Madrigal Pharmaceuticals logo
M
S
T
V

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems